Sergio Dompé
Description:
Born in Milan October 14, 1955, Sergio Dompé Group's President eponymous biopharmaceuticals, focused on the development of innovative therapeutic solutions for rare diseases, often orphan care. Entrepreneur of the Pharmaceutical and Biotechnology industry, have been conferred, in 1996, an Honorary Degree in Biotechnology with pharmaceutical address (Bologna), in 2005 in Medical Biotechnology (L'Aquila) and 2010 in Pharmacy (Urbino). Among the first in Italy to realize the true value of biotechnology applied to human health, it developed a dense network of partnerships with the most important research centers in diseases in the therapeutic areas in which concentrates its efforts Dompé. To date, Dompé has consolidated its commitment to R & D by promoting 21 clinical trials involving 1,200 patients worldwide, conducted in collaboration with an international network of 200 research centers. In 2016 finances and gives life to Movendo Company, an innovative medical company founded by the Italian Institute of Technology to develop the most advanced technologies in the service and products in the field of rehabilitation. In 2016 Sergio Dompé has been awarded the Foundation Aid to Research in Rare Diseases Award (ARMR), an award given to people who have distinguished themselves for their commitment in research, understood as a living witness.
Summary:
Born in Milan October 14, 1955, Sergio Dompé Group's President eponymous biopharmaceuticals, focused on the development of innovative therap...
Number of Registered Investments:1
Contact Details:
- Find the location here
- No email is provided
Find more here
Email is Not Provided
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.
English 
Polish 